Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duarte Pignatelli

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Cellular Biochemistry|September 27, 2018
MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumorsSofia S Pereira, Mariana P Monteiro, Madalena M Costa, et al.
Fertility and Sterility|August 17, 2015
Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoformCatarina Gonçalves, Margarida Bastos, Duarte Pignatelli, et al.
European Journal of Endocrinology|August 5, 2024
European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 QuestionnaireSarantis Livadas, Bulent O Yildiz, George Mastorakos, et al.
Journal of Cellular Biochemistry|November 26, 2016
Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and AdenomasSofia S Pereira, Valdemar Máximo, Ricardo Coelho, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Absence of central circadian pacemaker abnormalities in humans with loss of function mutation in prokineticin 2Ravikumar Balasubramanian, Daniel A Cohen, Elizabeth B Klerman, et al.
Biomedicines|April 30, 2021
Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and PhysiologySofia S Pereira, Liliana Carvalho, Madalena M Costa, et al.
Frontiers in Endocrinology|March 18, 2026
Follicular fluid from women with polycystic ovary syndrome induces granulosa cells metabolic dysfunction that is exacerbated by obesityMafalda V Moreira, Bárbara Guerra-Carvalho, David F Carrageta, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2007
Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadismNelly Pitteloud, Chengkang Zhang, Duarte Pignatelli, et al.
European Journal of Endocrinology|July 23, 2014
European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's QuestionnaireGerard Conway, Didier Dewailly, Evanthia Diamanti-Kandarakis, et al.
American Journal of Human Genetics|November 9, 2002
Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNADLionel Groussin, Lawrence S Kirschner, Caroline Vincent-Dejean, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Cellular Biochemistry|September 27, 2018
MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumorsSofia S Pereira, Mariana P Monteiro, Madalena M Costa, et al.
Fertility and Sterility|August 17, 2015
Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoformCatarina Gonçalves, Margarida Bastos, Duarte Pignatelli, et al.
European Journal of Endocrinology|August 5, 2024
European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 QuestionnaireSarantis Livadas, Bulent O Yildiz, George Mastorakos, et al.
Journal of Cellular Biochemistry|November 26, 2016
Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and AdenomasSofia S Pereira, Valdemar Máximo, Ricardo Coelho, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Absence of central circadian pacemaker abnormalities in humans with loss of function mutation in prokineticin 2Ravikumar Balasubramanian, Daniel A Cohen, Elizabeth B Klerman, et al.
Biomedicines|April 30, 2021
Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and PhysiologySofia S Pereira, Liliana Carvalho, Madalena M Costa, et al.
Frontiers in Endocrinology|March 18, 2026
Follicular fluid from women with polycystic ovary syndrome induces granulosa cells metabolic dysfunction that is exacerbated by obesityMafalda V Moreira, Bárbara Guerra-Carvalho, David F Carrageta, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2007
Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadismNelly Pitteloud, Chengkang Zhang, Duarte Pignatelli, et al.
European Journal of Endocrinology|July 23, 2014
European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's QuestionnaireGerard Conway, Didier Dewailly, Evanthia Diamanti-Kandarakis, et al.
American Journal of Human Genetics|November 9, 2002
Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNADLionel Groussin, Lawrence S Kirschner, Caroline Vincent-Dejean, et al.
Pageof 6